Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb 4:4:17.
doi: 10.1186/1755-8794-4-17.

A genome-wide association study of serum uric acid in African Americans

Affiliations

A genome-wide association study of serum uric acid in African Americans

Bashira A Charles et al. BMC Med Genomics. .

Abstract

Background: Uric acid is the primary byproduct of purine metabolism. Hyperuricemia is associated with body mass index (BMI), sex, and multiple complex diseases including gout, hypertension (HTN), renal disease, and type 2 diabetes (T2D). Multiple genome-wide association studies (GWAS) in individuals of European ancestry (EA) have reported associations between serum uric acid levels (SUAL) and specific genomic loci. The purposes of this study were: 1) to replicate major signals reported in EA populations; and 2) to use the weak LD pattern in African ancestry population to better localize (fine-map) reported loci and 3) to explore the identification of novel findings cognizant of the moderate sample size.

Methods: African American (AA) participants (n = 1,017) from the Howard University Family Study were included in this study. Genotyping was performed using the Affymetrix® Genome-wide Human SNP Array 6.0. Imputation was performed using MACH and the HapMap reference panels for CEU and YRI. A total of 2,400,542 single nucleotide polymorphisms (SNPs) were assessed for association with serum uric acid under the additive genetic model with adjustment for age, sex, BMI, glomerular filtration rate, HTN, T2D, and the top two principal components identified in the assessment of admixture and population stratification.

Results: Four variants in the gene SLC2A9 achieved genome-wide significance for association with SUAL (p-values ranging from 8.88 × 10(-9) to 1.38 × 10(-9)). Fine-mapping of the SLC2A9 signals identified a 263 kb interval of linkage disequilibrium in the HapMap CEU sample. This interval was reduced to 37 kb in our AA and the HapMap YRI samples.

Conclusions: The most strongly associated locus for SUAL in EA populations was also the most strongly associated locus in this AA sample. This finding provides evidence for the role of SLC2A9 in uric acid metabolism across human populations. Additionally, our findings demonstrate the utility of following-up EA populations GWAS signals in African-ancestry populations with weaker linkage disequilibrium.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of p-values from the multiple linear regression of SNPs, associated with uric acid. The red line indicates the genome-wide significance level 1 × 10-8 and the blue line indicates the suggestive significance level 1 × 10-6.
Figure 2
Figure 2
Local genetic architecture. Association p-values from multiple linear regression are shown based on physical position (NCBI build 36, dbSNP build 126). The light blue curve depicts the recombination rate from the combined Hap Map Phase II data. Linkage disequilibrium based on the HUFS sample is color-coded red for r2 to the top SNP ≥ 0.8, orange for r2 < 0.8 and ≥ 0.5, blue for r2 < 0.5 and ≥ 0.2, and gray for r2 < 0.20. Green arrows indicate the direction of transcription.
Figure 3
Figure 3
Comparison of linkage disequilibrium in the HapMap Phase II CEU and YRI data and our HUFS sample.

Similar articles

Cited by

References

    1. Johnson RJ, Rideout BA. Uric acid and diet--insights into the epidemic of cardiovascular disease. N Engl J Med. 2004;350(11):1071–1073. doi: 10.1056/NEJMp048015. - DOI - PubMed
    1. Mene P, Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease. Journal of Hypertension. 2008;26:2085–2092. doi: 10.1097/HJH.0b013e32830e4945. - DOI - PubMed
    1. Feig DI, Kang D-H, Johnson RJ. Uric Acid and cardiovascular disease. The New England Journal of Medicine. 2009;359(17):1811–1821. doi: 10.1056/NEJMra0800885. - DOI - PMC - PubMed
    1. van der Harst P, Bakker SJL, de Boer R, Wolffenbuttel BHR, Johnson T, Caulfield MJ, Navis g. Replication of the five novel loci for uric acid concentrates and potential mediating mechanisms. Human Molecular Genetics. 2010;19(2):387–395. doi: 10.1093/hmg/ddp489. - DOI - PubMed
    1. Cirillo P, Sato W, Reungjui S, Heinig M, Gersch M, Sautin Y, Nakagawa T, Johnson RJ. Uric acid, the metabolic syndrome, and renal disease. J Am Soc Nephrol. 2006;17(12 Suppl 3):S165–168. doi: 10.1681/ASN.2006080909. - DOI - PubMed

Publication types

MeSH terms

Substances